About A public-private partnership that supports the discovery of new medicines through open access research. About SGC Partners Research Laboratories SGC-Toronto SGC-UNC SGC-Frankfurt SGC-Karolinska SGC-Neuro Governance Collaborators Open Science Equity, Diversity and Inclusion Impact Science and Resources Proteins Structure Gallery Expression Vectors Plasmids Constructs Production Protocols ChromoHub Phylogenetic Trees UbiHub Phylogenetic Trees ChemBioPort Chemical Probes Program CHEMICAL PROBES Donated chemical probes Chemical Handles Human Kinase Chemical Probe Program ANTIBODIES TARGET ENABLING PACKAGES (TEPs) TISSUE PLATFORM Open Lab Notebooks Open Chemistry Network PUBLICATIONS People Global Aled Edwards, CEO Susan McCormick, CFO Max Morgan, General Counsel and Public Policy Director SGC Toronto Cheryl Arrowsmith Dalia Barsyte-Lovejoy Takis Prinos Matthieu Schapira Levon Halabelian Rachel Harding SGC UNC Tim Willson Alison Axtman David Drewry Peter J. Brown Rafael M. Couñago SGC UCL Mat Todd SGC Karolinska Michael Sundström Opher Gileadi SGC Frankfurt Stefan Knapp Susanne Müller-Knapp Thomas Hanke Vladimir Rogov Krishnal Saxena Andreas Joerger Václav Němec Andreas Krämer Sandra Röhm SGC Neuro Edward Fon Thomas Durcan Jean-François Trempe Ziv Gan-Or Peter McPherson Carl Laflamme Roxanne Lariviere News & Outreach News & Events News from SGC Press Releases Events Blog Tweets by thesgconline Careers
A public-private partnership that supports the discovery of new medicines through open access research.
Public Nomination of targets for SGCThe SGC aims to promote exploration of new drug targets for treatment of human diseases in four broad areas: Neuropsychiatry, Metabolic and rare diseases, Cancer, and Inflammation. Target * - Select -Metabolic and other rare diseasesNeuropsychiatry neurodegenerationCancerImmune Your name * Your email * Subject * Nomination comments and suggestions * File * Upload your SGC Excel nomination formFiles must be less than 2 MB.Allowed file types: xls xlsx. By clicking the 'submit' button, you consent to the University of Oxford collecting your details for the purposes of target nomination. The University of Oxford will use the information collected in the prioritisation of targets for TEP generation. Your data will not be passed on to any third party without your consent and you can at any time request that we remove your nominations from our internal records by emailing us at teps@thesgc.org. We reserve the right to disseminate summary statistics both publically and to third-parties which break down nominations by organisation type, target disease area, and other derived information obtained from publically accessible databases. The University of Oxford also reserves the right to disseminate a list of all genes nominated along with their corresponding target areas both publically and to third-parties. For clarity the only information provided which will be publically disseminated or shared with third-parties includes: Gene Symbol, Target Area, and Partner type (Industry, Charity, and Academia). We will not share any other information provided or share information publically or with third-parties which could be used to identify individuals or companies. Data will be held for the duration of the TEP project. CAPTCHAThis question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Math question * 6 + 6 = Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Public Nomination of targets for SGCThe SGC aims to promote exploration of new drug targets for treatment of human diseases in four broad areas: Neuropsychiatry, Metabolic and rare diseases, Cancer, and Inflammation. Target * - Select -Metabolic and other rare diseasesNeuropsychiatry neurodegenerationCancerImmune Your name * Your email * Subject * Nomination comments and suggestions * File * Upload your SGC Excel nomination formFiles must be less than 2 MB.Allowed file types: xls xlsx. By clicking the 'submit' button, you consent to the University of Oxford collecting your details for the purposes of target nomination. The University of Oxford will use the information collected in the prioritisation of targets for TEP generation. Your data will not be passed on to any third party without your consent and you can at any time request that we remove your nominations from our internal records by emailing us at teps@thesgc.org. We reserve the right to disseminate summary statistics both publically and to third-parties which break down nominations by organisation type, target disease area, and other derived information obtained from publically accessible databases. The University of Oxford also reserves the right to disseminate a list of all genes nominated along with their corresponding target areas both publically and to third-parties. For clarity the only information provided which will be publically disseminated or shared with third-parties includes: Gene Symbol, Target Area, and Partner type (Industry, Charity, and Academia). We will not share any other information provided or share information publically or with third-parties which could be used to identify individuals or companies. Data will be held for the duration of the TEP project. CAPTCHAThis question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Math question * 6 + 6 = Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.